{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:49:03Z","timestamp":1793450943539,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41401-019-0291-z","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T11:03:12Z","timestamp":1568286192000},"page":"260-269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo"],"prefix":"10.1038","volume":"41","author":[{"given":"Zhong-yan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-rong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-ting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"291_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA Cancer J Clin."},{"key":"291_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0234-3","volume":"36","author":"R Zheng","year":"2017","unstructured":"Zheng R, Zeng H, Zhang S, Chen W. Estimates of cancer incidence and mortality in China, 2013. Chin J Cancer. 2017;36:66.","journal-title":"Chin J Cancer"},{"key":"291_CR3","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1002\/jcp.26049","volume":"233","author":"M Mashreghi","year":"2018","unstructured":"Mashreghi M, Azarpara H, Bazaz MR, Jafari A, Masoudifar A, Mirzaei H, et al. Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. J Cell Physiol. 2018;233:2949\u201365.","journal-title":"J Cell Physiol."},{"key":"291_CR4","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182\u20136.","journal-title":"N Engl J Med."},{"key":"291_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3322\/caac.20075","volume":"60","author":"KM Cook","year":"2010","unstructured":"Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 2010;60:222\u201343.","journal-title":"CA Cancer J Clin."},{"key":"291_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/jcb.21442","volume":"103","author":"S Sakamoto","year":"2008","unstructured":"Sakamoto S, Ryan AJ, Kyprianou N. Targeting vasculature in urologic tumors: mechanistic and therapeutic significance. J Cell Biochem. 2008;103:691\u2013708.","journal-title":"J Cell Biochem"},{"key":"291_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ctrv.2012.04.006","volume":"38","author":"PM Hoff","year":"2012","unstructured":"Hoff PM, Machado KK. Role of angiogenesis in the pathogenesis of cancer. Cancer Treat Rev. 2012;38:825\u201333.","journal-title":"Cancer Treat Rev."},{"key":"291_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pbb.2009.04.021","volume":"93","author":"B Lee","year":"2009","unstructured":"Lee B, Jung K, Kim DH. Timosaponin AIII, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice. Pharmacol Biochem Behav. 2009;93:121\u20137.","journal-title":"Pharmacol Biochem Behav"},{"key":"291_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jep.2014.02.013","volume":"153","author":"Y Wang","year":"2014","unstructured":"Wang Y, Dan Y, Yang D, Hu Y, Zhang L, Zhang C, et al. The genus Anemarrhena Bunge: a review on ethnopharmacology, phytochemistry and pharmacology. J Ethnopharmacol. 2014;153:42\u201360.","journal-title":"J Ethnopharmacol."},{"key":"291_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.intimp.2015.02.016","volume":"25","author":"S-M Lim","year":"2015","unstructured":"Lim SM, Jeong JJ, Kang GD, Kim KA, Choi HS, Kim DH. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-\u03baB and MAPK activation and restoring Th17\/Treg cell balance. Int Immunopharmacol. 2015;25:493\u2013503.","journal-title":"Int Immunopharmacol"},{"key":"291_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep38757","volume":"6","author":"Y Cong","year":"2016","unstructured":"Cong Y, Wang L, Peng R, Zhao Y, Bai F, Yang C, et al. Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor. Sci Rep. 2016;6:38757.","journal-title":"Sci Rep"},{"key":"291_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/08923970903383889","volume":"32","author":"B Lee","year":"2010","unstructured":"Lee B, Trinh HT, Jung K, Han SJ, Kim DH. Inhibitory effects of steroidal timosaponins isolated from the rhizomes of Anemarrhena asphodeloides against passive cutaneous anaphylaxis reaction and pruritus. Immunopharmacol Immunotoxicol. 2010;32:357\u201363.","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"291_CR13","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/aps.2014.65","volume":"35","author":"Z-t Wu","year":"2014","unstructured":"Wu ZT, Qi XM, Sheng JJ, Ma Ll, Ni X, Ren J, et al. Timosaponin A3 induces hepatotoxicity in rats through inducing oxidative stress and down-regulating bile acid transporters. Acta Pharmacol Sin. 2014;35:1188\u201398.","journal-title":"Acta Pharm Sin"},{"key":"291_CR14","doi-asserted-by":"crossref","unstructured":"Han FY, Song XY, Chen JJ, Yao GD, Song SJ. Timosaponin AIII: a novel potential anti-tumor compound from Anemarrhena asphodeloides. Steroids. 2018;140:125\u201330.","DOI":"10.1016\/j.steroids.2018.09.014"},{"key":"291_CR15","doi-asserted-by":"publisher","first-page":"e7283","DOI":"10.1371\/journal.pone.0007283","volume":"4","author":"FW King","year":"2009","unstructured":"King FW, Fong S, Griffin C, Shoemaker M, Staub R, Zhang Y-L, et al. Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress. PLoS One. 2009;4:e7283.","journal-title":"PLoS One"},{"key":"291_CR16","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1016\/j.bmcl.2016.07.004","volume":"26","author":"O Jung","year":"2016","unstructured":"Jung O, Lee J, Lee YJ, Yun JM, Son YJ, Cho JY, et al. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1\/2, Src\/FAK and \u03b2-catenin signaling pathways. Bioorg Med Chem Lett. 2016;26:3963\u20137.","journal-title":"Bioorg Med Chem Lett."},{"key":"291_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/2211-5463.12457","volume":"8","author":"CB MarElia","year":"2018","unstructured":"MarElia CB, Sharp AE, Shemwell TA, Clare Zhang Y, Burkhardt BR. Anemarrhena asphodeloides Bunge and its constituent timosaponin\u2010AIII induce cell cycle arrest and apoptosis in pancreatic cancer cells. FEBS Open Bio. 2018;8:1155\u201366.","journal-title":"FEBS Open Bio"},{"key":"291_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12272-016-0763-3","volume":"40","author":"Y Wang","year":"2017","unstructured":"Wang Y, Xu L, Lou LL, Song SJ, Yao GD, Ge MY, et al. Timosaponin AIII induces apoptosis and autophagy in human melanoma A375-S2 cells. Arch Pharm Res. 2017;40:69\u201378.","journal-title":"Arch Pharm Res."},{"key":"291_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/cas.12852","volume":"107","author":"KM Kim","year":"2016","unstructured":"Kim KM, Im AR, Kim SH, Hyun JW, Chae S. Timosaponin AIII inhibits melanoma cell migration by suppressing COX\u20102 and in vivo tumor metastasis. Cancer Sci. 2016;107:181\u20138.","journal-title":"Cancer Sci"},{"key":"291_CR20","doi-asserted-by":"crossref","unstructured":"Tsai CH, Yang CW, Wang JY, Tsai YF, Tseng LM, King KL, et al. Timosaponin AIII suppresses hepatocyte growth factor-induced invasive activity through sustained ERK activation in breast cancer MDA-MB-231 cells. J Evid Based Integr Med. 2013;2013:421051.","DOI":"10.1155\/2013\/421051"},{"key":"291_CR21","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1016\/j.bbamcr.2013.07.018","volume":"1833","author":"N Wang","year":"2013","unstructured":"Wang N, Feng Y, Zhu M, Siu FM, Ng KM, Che CM. A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma. Biochim Biophys Acta Mol Cell Res. 2013;1833:2890\u20139.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"291_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1021\/np1007735","volume":"74","author":"Y-J Kang","year":"2011","unstructured":"Kang YJ, Chung HJ, Nam JW, Park HJ, Seo EK, Kim YS, et al. Cytotoxic and antineoplastic activity of timosaponin A-III for human colon cancer cells. J Nat Prod. 2011;74:701\u20136.","journal-title":"J Nat Prod."},{"key":"291_CR23","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s13277-014-2985-7","volume":"36","author":"H-L Huang","year":"2015","unstructured":"Huang HL, Chiang WL, Hsiao PC, Chien MH, Chen HY, Weng WC, et al. Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1\/2 pathway in human promyelocytic leukemia cells. Tumour Biol. 2015;36:3489\u201397.","journal-title":"Tumour Biol"},{"key":"291_CR24","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3892\/ijo.2016.3423","volume":"48","author":"J-R Chen","year":"2016","unstructured":"Chen JR, Jia XH, Wang H, Yi YJ, Wang JY, Li YJ. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562\/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K\/Akt signaling pathway. Int J Oncol. 2016;48:2063\u201370.","journal-title":"Int J Oncol."},{"key":"291_CR25","first-page":"525","volume":"13","author":"B Huang","year":"2017","unstructured":"Huang B, Peng Y, Li J, Li S, Sun Y, Wang D, et al. An andrographolide derivative AGP-26b exhibiting anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA\/VEGFR2 signaling pathway. Mol Omics. 2017;13:525\u201336.","journal-title":"Mol Omics"},{"key":"291_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jep.2016.10.075","volume":"200","author":"Z-Y Zhou","year":"2017","unstructured":"Zhou ZY, Huan LY, Zhao WR, Tang N, Jin Y, Tang JY. Spatholobi Caulis extracts promote angiogenesis in HUVECs in vitro and in zebrafish embryos in vivo via up-regulation of VEGFRs. J Ethnopharmacol. 2017;200:74\u201383.","journal-title":"J Ethnopharmacol."},{"key":"291_CR27","first-page":"338","volume":"15","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Li Y, Liu G, Qi X, Cao X. MicroRNA-24 inhibits the proliferation and migration of endothelial cells in patients with atherosclerosis by targeting importin-\u03b13 and regulating inflammatory responses. Exp Ther Med. 2018;15:338.","journal-title":"Exp Ther Med"},{"key":"291_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/febs.14123","volume":"285","author":"EK Paterson","year":"2018","unstructured":"Paterson EK, Courtneidge SA. Invadosomes are coming: new insights into function and disease relevance. FEBS J. 2018;285:8\u201327.","journal-title":"FEBS J"},{"key":"291_CR29","doi-asserted-by":"crossref","unstructured":"Singh P, Jenkins LM, Horst B, Alers V, Pradhan S, Kaur P, et al. Inhibin is a novel paracrine factor for tumor angiogenesis and metastasis. Cancer Res. 2018;78:2978\u201389.","DOI":"10.1158\/0008-5472.CAN-17-2316"},{"key":"291_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jep.2011.08.052","volume":"141","author":"Z-F Zhong","year":"2012","unstructured":"Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, et al. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo. J Ethnopharmacol. 2012;141:721\u20137.","journal-title":"J Ethnopharmacol."},{"key":"291_CR31","doi-asserted-by":"publisher","first-page":"13332","DOI":"10.1002\/jcp.28010","volume":"234","author":"KC Chiang","year":"2019","unstructured":"Chiang KC, Lai CY, Chiou HL, Lin CL, Chen YS, Kao SH, et al. Timosaponin AIII inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT\/miR-129-5p axis. J Cell Physiol. 2019;234:13332\u201341.","journal-title":"J Cell Physiol."},{"key":"291_CR32","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mc.22804","volume":"57","author":"JE Gergely","year":"2018","unstructured":"Gergely JE, Dorsey AE, Dimri GP, Dimri M. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells. Mol Carcinog. 2018;57:831\u201341.","journal-title":"Mol Carcinog."},{"key":"291_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2017.10.008","volume":"815","author":"Z-Y Zhou","year":"2017","unstructured":"Zhou ZY, Xu JQ, Zhao WR, Chen XL, Jin Y, Tang N, et al. Ferulic acid relaxed rat aortic, small mesenteric and coronary arteries by blocking voltage-gated calcium channel and calcium desensitization via dephosphorylation of ERK1\/2 and MYPT1. Eur J Pharmacol. 2017;815:26\u201332.","journal-title":"Eur J Pharmacol"},{"key":"291_CR34","doi-asserted-by":"crossref","unstructured":"Zhou ZY, Zhao WR, Shi WT, Xiao Y, Ma ZL, Xue JG, et al. Endothelial-dependent and independent vascular relaxation effect of tetrahydropalmatine on rat aorta. Front Pharmacol. 2019;10:336.","DOI":"10.3389\/fphar.2019.00336"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0291-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:19Z","timestamp":1684616539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0291-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0291-z","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}